Comoros vs Egypt: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Comoros
0.0%
in 2025
Egypt
0.0%
in 2025
Comoros rank
165th
Egypt rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Comoros
- Egypt
How they compare
Comoros currently reports 0.0% against 0.0% in Egypt, a difference of 0.0%.
Across all 18 years both countries report, Egypt has been ahead every year.
Comoros ranks 165th and Egypt ranks 165th of 192 countries.
Head to head by decade
| Decade | Comoros | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 0.0% | 0.0% | 0.0% | β |
| 2020s | 0.0% | 0.0% | 0.0% | β |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Comoros or Egypt?
- Comoros, at 0.0% against 0.0% in Egypt as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Comoros and Egypt?
- 0.0%, with Comoros ahead.
- How many years of comparable data are there for Comoros and Egypt?
- 18 years are reported by both, from 2008 to 2025.
- How do Comoros and Egypt rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Comoros ranks 165th and Egypt ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.